TERN Stock Analysis: Buy, Sell, or Hold?
TERN - Terns Pharmaceuticals, Inc. Common Stock
$52.95
0.02 (0.04%)
▲
5d:
+0.0%
30d:
+0.44%
90d:
+43.81%
HOLD
MODERATE Confidence
Analysis Updated: May 4, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 7.0/10
Get Alerted When TERN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TERN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TERN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TERN is currently trading at $52.95, which is considered extended relative to its 30-day fair value range of $52.65 to $52.91.
Technical Outlook: Technically, TERN is in a strong uptrend. The price is currently testing key support at $52.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TERN is in a strong uptrend. The price is currently testing key support at $52.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$52.65 -
$52.91
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
TERN is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($53.00)
Trading Range Analysis
30-Day Trading Range
$52.65 -
$52.91
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.25
(4.3%)
Support & Resistance Levels
Support Level
$52.71
Resistance Level
$52.98
Current Trend
Strong Uptrend
Technical data as of
May 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-35.99
Wall Street Target
$53.00
(+0.1%)
Share & Embed Analysis
Last updated: May 14, 2026 1:43 PM ET
Data refreshes hourly during market hours. Next update: 2:43 PM
Data refreshes hourly during market hours. Next update: 2:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TERN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Emil Kuriakose
SELL
942 shares
2026-04-01
Amy L Burroughs
SELL
14583 shares
2026-03-16
Amy L Burroughs
SELL
14583 shares
2026-02-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 54 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 53 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 55 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$73 | 54 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 59 HOLD |
Advanced TERN Option Strategies
Professional options setups generated by AI based on today's TERN price and gamma walls.
